Sign In

Bob Nelson

Vice President of Biology at MindImmune Therapeutics, Inc.

Bob Nelson is a seasoned professional with over 25 years of experience in small molecule- and antibody-based pharmaceutical drug discovery, focusing on cerebrovascular inflammation in neurodegenerative diseases. Currently serving as the Vice President of Biology and Co-Founder at MindImmune Therapeutics, Inc., Bob leads research efforts investigating the role of peripheral innate immune cells in Alzheimer's disease. His prior role at Lundbeck Research USA involved spearheading the identification of immune mechanisms affecting multiple neurological disorders. Bob's expertise includes project leadership, resulting in nominations for clinical development, notably a Phase III candidate targeting neuroinflammation in Alzheimer's disease.

Bob Nelson
Add to my network

Location

Kingston, Rhode Island